drugset
drugset / Trial / NCT01418092

ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)

NCT01418092 ↗

Phase 2 Completed 91 enrolled Alkermes, Inc.
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of ALKS 37 when administered daily to adults with OIC.

Timeline

Start
2011-09
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject METHYLSAMIDORPHAN Small molecule — Oral

Indications

opioid-induced constipation